Repligen Corp
(NAS:RGEN)
$
120.77
0.63 (0.52%)
Market Cap: 6.75 Bil
Enterprise Value: 6.71 Bil
PE Ratio: 483.08
PB Ratio: 3.42
GF Score: 96/100 - Q1 2024 Repligen Corp Earnings Call TranscriptMay 01, 2024$158.36 (-3.56%)Earnings
- Q4 2023 Repligen Corp Earnings Call TranscriptFeb 21, 2024$194.1 (-2.82%)Earnings
- Repligen Corp at JPMorgan Healthcare Conference TranscriptJan 09, 2024
- Repligen Corp at Stephens Investment Conference TranscriptNov 16, 2023
- Repligen Corp at Stifel Healthcare Conference TranscriptNov 15, 2023
- Q3 2023 Repligen Corp Earnings Call TranscriptOct 31, 2023$134.56 (+17.86%)Earnings
- Repligen Corp at Wells Fargo Healthcare Conference TranscriptSep 08, 2023
- Q2 2023 Repligen Corp Earnings Call TranscriptAug 02, 2023$170.48 (+2.01%)Earnings
- Repligen Corp at Jefferies Healthcare Conference TranscriptJun 08, 2023
- Repligen Corp at William Blair Growth Stock Conference TranscriptJun 08, 2023
- Q1 2023 Repligen Corp Earnings Call TranscriptMay 02, 2023$157.23 (+2.40%)Earnings
- Repligen Corp at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum (Virtual) TranscriptMar 21, 2023
- Q4 2022 Repligen Corp Earnings Call TranscriptFeb 22, 2023$169.98 (-4.51%)Earnings
- Repligen Corp at JPMorgan Healthcare Conference TranscriptJan 10, 2023
- Repligen Corp at Stephens Investment Conference TranscriptNov 17, 2022
- Repligen Corp at Stifel Healthcare Conference TranscriptNov 16, 2022
- Q3 2022 Repligen Corp Earnings Call TranscriptNov 01, 2022$185.55 (+1.68%)Earnings
- Repligen Corp Investor Day TranscriptSep 20, 2022
- Q2 2022 Repligen Corp Earnings Call TranscriptAug 02, 2022$237.38 (+11.68%)Earnings
- Repligen Corp at Jefferies Healthcare Conference TranscriptJun 09, 2022
- Repligen Corp at William Blair Growth Stock Conference TranscriptJun 07, 2022
- Q1 2022 Repligen Corp Earnings Call TranscriptApr 27, 2022$157.51 (+10.49%)Earnings
- Repligen Corp at KeyBanc Capital Markets Life Sciences & MedTech Forum (Virtual) TranscriptMar 22, 2022
- Repligen Corp at SVB Leerink Global Healthcare (Virtual) TranscriptFeb 18, 2022
- Q4 2021 Repligen Corp Earnings Call TranscriptFeb 17, 2022$182.42 (-0.87%)Earnings
- Repligen Corp at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2022
- Repligen Corp at Stifel Healthcare Conference (Virtual) TranscriptNov 17, 2021
- Q3 2021 Repligen Corp Earnings Call TranscriptOct 28, 2021$290.02 (+7.00%)Earnings
- Q2 2021 Repligen Corp Earnings Call TranscriptJul 27, 2021$226.38 (+9.89%)Earnings
- Repligen Corp at Jefferies Healthcare Conference (Virtual) TranscriptJun 03, 2021
- Repligen Corp at William Blair Growth Stock Conference (Virtual) TranscriptJun 01, 2021
- Q1 2021 Repligen Corp Earnings Call TranscriptMay 04, 2021$194.67 (-6.46%)Earnings
- Repligen Corp at KeyBanc Capital Markets Life Sciences & Medtech Investor Forum (virtual) TranscriptMar 24, 2021
- Repligen Corp at Barclays Global Healthcare Conference (Virtual) TranscriptMar 10, 2021
- Repligen Corp at SVB Leerink Global Healthcare Conference (Virtual) TranscriptFeb 26, 2021
- Q4 2020 Repligen Corp Earnings Call TranscriptFeb 24, 2021$215.58 (+4.39%)Earnings
- Repligen Corp at JPMorgan Healthcare Conference (Virtual) TranscriptJan 13, 2021
- Repligen Corp at Stephens NASH Investment Conference (Virtual) TranscriptNov 19, 2020
- Repligen Corp at Stifel Virtual Healthcare Conference TranscriptNov 18, 2020
- Q3 2020 Repligen Corp Earnings Call TranscriptNov 05, 2020$201.86 (+8.02%)Earnings
- Q2 2020 Repligen Corp Earnings Call TranscriptJul 30, 2020$151.25 (+8.99%)Earnings
- Repligen Corp at William Blair Growth Stock Conference TranscriptJun 11, 2020
- Repligen Corp at Jefferies Healthcare Conference (Virtual) TranscriptJun 03, 2020
- Repligen Corp at UBS Global Healthcare Conference (Virtual) TranscriptMay 18, 2020
- Repligen Corp Annual Shareholders Meeting TranscriptMay 13, 2020
- Q1 2020 Repligen Corp Earnings Call TranscriptMay 06, 2020$124.71 (+8.90%)Earnings
- Repligen Corp at Barclays Global Healthcare Conference TranscriptMar 11, 2020
- Q4 2019 Repligen Corp Earnings Call TranscriptFeb 20, 2020$101.12 (-7.35%)Earnings
- Repligen Corp at JPMorgan Healthcare Conference TranscriptJan 15, 2020
- Q3 2019 Repligen Corp Earnings Call TranscriptOct 31, 2019$79.49 (+3.05%)Earnings
- Q2 2019 Repligen Corp Earnings Call TranscriptAug 01, 2019$95.51 (+1.19%)Earnings
- Repligen Corp at UBS Global Healthcare Conference TranscriptMay 21, 2019
- Q1 2019 Repligen Corp Earnings Call TranscriptMay 09, 2019$69.86 (+3.39%)Earnings
- Repligen Corp to Acquire C Technologies Inc - M&A Call TranscriptApr 26, 2019
- Q4 2018 Repligen Corp Earnings Call TranscriptFeb 21, 2019$58.05 (-1.61%)Earnings
Repligen Corp at SVB Leerink Global Healthcare Conference (Virtual) Transcript
Feb 26, 2021 / 05:00PM GMT
Release Date Price:
$212.39
(+2.57%)
Puneet Souda
SVB Leerink LLC, Research Division - MD of Life Science Tools & Diagnostics and Senior Research Analyst
Okay. Great. Welcome, everyone. I'm Puneet Souda, SVB Leerink tools and diagnostic analyst here. And it's a pleasure to be hosting Repligen management team. Joining us from Repligen is Tony Hunt, CEO; and Jon Snodgres, CFO. Hey guys, welcome. Glad to have you here.
Anthony J. Hunt
Repligen Corporation - CEO, President & Director
Puneet, good to see you.
Puneet Souda
SVB Leerink LLC, Research Division - MD of Life Science Tools & Diagnostics and Senior Research Analyst
Great. So just before we get started, I mean, to me, look, Repligen is a high-growth company in the bioprocessing space that is benefiting COVID vaccine ramp and is increasingly seeing growth from high-growth markets of cell and gene therapy. So obviously, a lot to cover here. Please send me questions through the chat if you have any or through e-mail, and we'll cover them during the session.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)